Feagan BG, Matsuoka K, Rogler G, Laharie D, et al. Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Aliment Pharmacol Ther 2024 Jul 31. doi: 10.1111/apt.18158.
PMID: 39086130